SavedAdd your journal

Journals / Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni / 2026 / Cilt: 17 Sayı: 2026

The Role of Medicinal Plants with Hypoglycemic Properties in Blood Glucose Regulation

Hipoglisemik Özelliklere Sahip Tıbbi Bitkilerin Kan Şekeri Regülasyonundaki Rolü

Sinem Pehlivan(ANKARA MEDİPOL ÜNİVERSİTESİ)0000-0002-3389-3189
Maryam Faraji(ANKARA MEDİPOL ÜNİVERSİTESİ)0009-0008-2203-8225
İclal Altınay(ANKARA MEDİPOL ÜNİVERSİTESİ)0009-0006-2025-6347
Pages
—
Publication Date
2026-08-25
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the hypoglycemic effects and therapeutic potential of Punica granatum, Gymnema sylvestre, Momordica charantia, Andrographis paniculata, Bongardia chrysogonum, Viburnum opulus, Gundelia tournefortii, Berberis Vulgaris and Trigonella foenum-graecum will be discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetes mellitus (DM) is characterized by impaired glucose metabolism and hyperglycemia that can lead to significant clinical consequences.
📊
Key Findings & Data:Limited insulin release, insulin resistance or both of conditions lead to impaired metabolism of fats, proteins and carbohydrates in the body, and the resulting hyperglycemia increases the reactive oxygen species (ROS) formation.
💡
Conclusion & Impact:In this review, the hypoglycemic effects and therapeutic potential of Punica granatum, Gymnema sylvestre, Momordica charantia, Andrographis paniculata, Bongardia chrysogonum, Viburnum opulus, Gundelia tournefortii, Berberis Vulgaris and Trigonella foenum-graecum will be discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Antioksidan · Diabetes Mellitus · Hiperglisemi

Abstract

Diabetes mellitus (DM) is characterized by impaired glucose metabolism and hyperglycemia that can lead to significant clinical consequences. Limited insulin release, insulin resistance or both of conditions lead to impaired metabolism of fats, proteins and carbohydrates in the body, and the resulting hyperglycemia increases the reactive oxygen species (ROS) formation. In the literature, there are numerous studies showing that plant-based formulations may have therapy potential in DM thanks to their anti-inflammatory, hypoglycemic actions, antioxidant properties. In this review, the hypoglycemic effects and therapeutic potential of Punica granatum, Gymnema sylvestre, Momordica charantia, Andrographis paniculata, Bongardia chrysogonum, Viburnum opulus, Gundelia tournefortii, Berberis Vulgaris and Trigonella foenum-graecum will be discussed.

Özet

Diabetes mellitus (DM), önemli klinik sonuçlara yol açabilen hiperglisemi ile seyreden, glukoz metabolizmasının bozulmasıyla karakterize bir hastalıktır. Sınırlı insülin salgılanması, insülin direnci veya her iki durumun bir arada bulunması, vücuttaki yağ, protein ve karbonhidrat metabolizmasının bozulmasına yol açmakta; ortaya çıkan hiperglisemi ise reaktif oksijen türleri (ROS) üretimini artırmaktadır. Literatürde, bitki bazlı formülasyonların antioksidan özelliklerinin yanı sıra anti-İnflamatuar ve hipoglisemik etkileri nedeniyle DM’de terapötik potansiyele sahip olabileceğini gösteren çok sayıda çalışma bulunmaktadır. Bu derlemede Punica granatum, Gymnema sylvestre, Momordica charantia, Andrographis paniculata, Bongardia chrysogonum, Viburnum opulus, Gundelia tournefortii, Berberis Vulgaris ve Trigonella foenum-graecum, bitkilerinin diyabet yönetiminde hipoglisemik etkileri ve tedavi potansiyelleri tartışılacaktır.

🔖

Cite This Article

Pehlivan, S., Faraji, M., Altınay, İ. (2026). The Role of Medicinal Plants with Hypoglycemic Properties in Blood Glucose Regulation. Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni, Cilt: 17 Sayı: 2026. https://doi.org/10.38137/vftd.1765922

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (110)

  1. Acıbuca V, Budak DB. (2018). Dünya’da ve Türkiye’de tıbbi ve aromatik bitkilerin yeri ve önemi. Çukurova Tarım ve Gıda Bilimleri Dergisi, 33, 37-44.
  2. Adriawan IR, Andrie M, Susilowati R, Pramono S, Nugroho AE. (2014). Evaluasi efek anti-diabetes melitus ekstrak terpurifikasi Andrographis paniculata (Burm. f.) Nees dan andrografolid dengan parameter indeks HOMA-IR. Trad Med J, 19(1), 19–23.
  3. Ahmad I, Adeghate E, Cummings E, Sharma AK, Singh J. (2004). Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin induced diabetes mellitus in rats. Mol Cell Biochem, 261, 63–70.
  4. Akhtar MT, Bin Mohd Sarib MS, Ismail IS, Abas F, Ismail A et al. (2016). Anti-diabetic activity and metabolic changes induced by Andrographis paniculata plant extract in obese diabetic rats. Molecules, 21(8), 1026.
  5. Akbar S. (2011). Andrographis paniculata: a review of pharmacological activities and clinical effects. Altern Med Rev, 16(1), 66–77.
  6. Aksoy A, Güvensan A, Akçiçek E, Oztürk M. (2004). Etnoecology of Viburnum opulus L. International Symposium on Medicinal Plants: Linkages Beyond National Boundaries, 7-9 September 2004, Islamabad, Pakistan, 65-70.
  7. Alarcon-Aguilara FJ, Roman-Ramos R, Perez-Gutierrez S, Aguilar-Contreras A, Contreras-Weber CC et al. (1998). Study of the anti-hyperglycemic effect of plants used as antidiabetics. J Ethnopharmacol, 61(2), 101-110.
  8. Al-Habori M, Raman A, Lawrence MJ, Skett P. (2001). In vitro effect of fenugreek extracts on intestinal sodium-dependent glucose uptake and hepatic glycogen phosphorylase A. Int J Exp Diabetes Res, 2, 91-99.
  9. Altun ML, Çitoğlu GS, Yilmaz BS, Özbek H. (2009). Antinociceptive and anti-inflammatory activities of Viburnum opulus. Pharm Biol, 47, 653-658.
  10. Altun ML, Yılmaz BS. (2007). HPLC method for the analysis of salicin and chlorogenic acid from Viburnum opulus and V. lantana. Chem Nat Compd, 43, 205-207.
  11. Andreeva TI, Komarova EN, Yusubov MS, Korotkova EI. (2004). Medicinal plants, antioxidant activity of cranberry tree (Viburnum opulus L.) bark extract. Pharm Chem J, 38, 548-550.
  12. Arayne MS, Sultana N, Bahadur SS. (2007). The berberis story: Berberis vulgaris in therapeutics. Pak J Pharm Sci, 20(1), 83-92.
  13. Arslan ACE, Ozaslan M, Cengiz B, Bagci C, Tarakcioglu M et al. (2005). The effects of Bongardia chrysogonum spach extract on the serum parameters and liver, kidney, and spleen tissues in rats. Biotechnol Biotechnol Eq, 19, 3-19.
  14. Arumugam G, Manjula P, Paari N. (2013). A review: Antidiabetic medicinal plants used for diabetes mellitus. J Acute Dis, 2, 196-200.
  15. Asadi-Samani M, Rafieian-Kopaei M, Azimi N. (2013). Gundelia: a systematic review of medicinal and molecular perspective. Pak J Biol Sci, 16(21), 1238-1247.
  16. Baskaran K, Ahamath BK, Shanmugasundaram KR, Shanmugasundaram ERB. (1990). Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol, 30(3), 295–300.
  17. Baytop T. (1999). Therapy with medicinal plants in Turkey (2nd ed.). İstanbul, Nobel Tıp Kitabevleri, 210. Beckman JA, Creager MA, Libby P. (2002). Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA, 287(19), 2570-2581.
  18. Bidulka P, Lugo-Palacios DG, Carroll O, O’Neill S, Adler AI et al. (2024). Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data. BMJ, 385, e077658.
  19. Cesonienė L, Daubaras R, Viškelis P, Sarkinas A. (2012). Determination of the total phenolic and anthocyanin contents and antimicrobial activity of Viburnum opulus fruit juice. Plant Foods Hum Nutr, 67, 256-261.
  20. Chen S, Kristiana A, Suryoprabowo S. (2025). Anti-diabetic compounds from Physalis angulata L. (ciplukan) and Andrographis paniculata: a review. IOP Conf Ser Earth Environ Sci, 1445(1), 012002.
  21. Cheung KKT, Luk AOY, So WY, Ma RCW, Kong APS et al. (2015). Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence. J Diabetes Investig, 6(2), 112–123.
  22. Crista ME, Butnariu M. (2023). Berberis vulgaris—a shrub that contains nutraceuticals. Int J Biomed Res, 2(1), 10-2834-8087.
  23. Çam M. (2005). Kayseri Bölgesi’nde tüketilen gilaburu (Viburnum opulus) meyve suyunun organik asit ve fenolik bileşiklerinin yüksek basınç sıvı kromotografisi (HPLC) ile belirlenmesi. Yüksek lisans tezi, Ege Üniversitesi Fen Bilimleri Enstitüsü.
  24. Çiçek SS (2022). Momordica charantia L.—diabetes-related bioactivities, quality control, and safety considerations. Front Pharmacol, 13, 904643.
  25. Dağli ŞN, Demir T, Kaplan DS, Doğru NÖ, Bahar AY et al. (2022). Diyabetik nefropati modeli oluşturulmuş sıçanlarda Bongardia chrysogonum’un etkisinin incelenmesi. Gevher Nesibe J Med Health Sci, 7(18), 33-41.
  26. Dans AM, Villarruz MVC, Jimeno CA, Javelosa MAU, Chua J et al. (2007). The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus: a randomized double-blind clinical trial. J Clin Epidemiol, 60(6), 554–559.
  27. Das S, Barman S. (2012). Antidiabetic and antihyperlipidemic effects of ethanolic extract of leaves of Punica granatum in alloxan-induced non–insulin-dependent diabetes mellitus albino rats. Indian J Pharmacol, 44(2), 219-224.
  28. Demir T, Akpınar Ö, Kara H, Güngör H. (2019). Nar (Punica granatum L.) kabuğunun in vitro antidiyabetik, antienflamatuar, sitotoksik, antioksidan ve antimikrobiyal aktivitesi. Akademik Gıda, 17, 61-71.
  29. Dokuyucu R, Gozukara KH, Ozcan O, Sefil NK, Nacar A et al. (2016). The effect of Bongardia chrysogonum on prostate tissue in a rat model of STZ-induced diabetes. SpringerPlus, 5(1), 1322.
  30. Dykes L, Rooney LW. (2007). Phenolic compounds in cereal grains and their health benefits. Cereal Foods World, 52, 105-111.
  31. Ekor M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol, 4, 177.
  32. Ergün F. (2025). C. tournefortii meyve ve yapraklarının antioksidan aktivitesi. International Congresses of Turkish Science and Technology Publishing, 381-386.
  33. Feingold KR. (2024). Oral and injectable (non-insulin) pharmacological agents for the treatment of type 2 diabetes. In: Feingold, K. R., Anawalt, B., Boyce, A., et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.
  34. Gallego Muñoz C, Ferreira Alfaya FJ. (2015). Plantas medicinales en el tratamiento de la diabetes mellitus tipo 2: una revisión. Farm Comunitarios, 7, 27-34.
  35. Gharib E, Kouhsari SM. (2019). Study of the antidiabetic activity of Punica granatum L. fruits aqueous extract on the alloxan-diabetic Wistar rats. Iran J Pharm Res, 18(1), 358–366.
  36. Grover JK, Yadav SP. (2004). Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol, 93(1), 123–132.
  37. Haghi G, Hatami A, Arshi R. (2011). Distribution of caffeic acid derivatives in Gundelia tournefortii L. Food Chem, 124, 1029-1035.
  38. Hajizadeh-Sharafabad F, Alizadeh M, Mohammadzadeh MHS, Alizadeh-Salteh S, Kheirouri S. (2016). Effect of Gundelia tournefortii L. extract on lipid profile and TAC in patients with coronary artery disease: a double-blind randomized placebo-controlled clinical trial. J Herb Med, 6(2), 59-66.
  39. Hajzadeh M, Rajaei Z, Shafiee S, Alavinejhad A, Samarghandian S et al. (2011). Effect of barberry fruit (Berberis vulgaris) on serum glucose and lipids in streptozotocin-diabetic rats. Pharmacologyonline, 1, 809-817. Harden GJ. (2000). Flora of New South Wales. Vol. 1. Kensington: NSW University Press.
  40. Haxhiraj M, White K, Terry C. (2024). The role of fenugreek in the management of type 2 diabetes. Int J Mol Sci, 25(13), 6987.
  41. Hidayat R, Wulandari P. (2021). Effects of Andrographis paniculata (Burm. F.) extract on diabetic nephropathy in rats. Rep Biochem Mol Biol, 10, 445-454.
  42. Hossain MS, Urbi Z, Sule A, Rahman KM. (2014). Andrographis paniculata (Burm. f.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacology. ScientificWorldJournal, 2014, 274905.
  43. Jamshidzadeh F, Fereidooni Z, Salehi H, Niknahad H. (2005). Hepatoprotective activity of Gundelia tournefortii. J Ethnopharmacol, 101(1-3), 233-237.
  44. Jarukamjorn K, Nemoto N. (2008). Pharmacological aspects of Andrographis paniculata on health and its major diterpenoid constituent andrographolide. J Health Sci, 54(4), 370-381.
  45. Jayaweera DMA. (1981). Medicinal plant: part III. Peradeniya: Sri Lanka Royal Botanic Garden, 225 pp.
  46. Joseph B, Jini D. (2013). Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac J Trop Dis, 3(2), 93–102.
  47. Kadan S, Sasson Y, Saad B, Zaid H. (2018). Gundelia tournefortii antidiabetic efficacy: Chemical composition and GLUT4 translocation. Evid Based Complement Alternat Med, 2018, 8294320.
  48. Kadan S, Melamed S, Benvalid S, Tietel Z, Sasson Y et al. (2021). Gundelia tournefortii: fractionation, chemical composition and GLUT4 translocation enhancement in muscle cell line. Molecules, 26(13), 3785.
  49. Kajszczak D, Zakłos-Szyda M, Podsędek A. (2020). Viburnum opulus L.—a review of phytochemistry and biological effects. Nutrients, 12(11), 3398.
  50. Kajszczak D, Kowalska-Baron A, Podsędek A. (2021). Glycoside hydrolases and non-enzymatic glycation inhibitory potential of Viburnum opulus L. fruit—in vitro studies. Antioxidants (Basel), 10(6), 989.
  51. Kanetkar P, Singhal R, Kamat M. (2007). Gymnema sylvestre: a memoir. J Clin Biochem Nutr, 41(2), 77-81.
  52. Kaur M. (2016). To study the efficacy and tolerability of fenugreek seed powder as add-on therapy with metformin in patients of type-2 diabetes mellitus. Int J Basic Clin Pharmacol, 5(4), 1414–141.
  53. Khan F, Sarker MMR, Ming LC, Mohamed IN, Zhao C et al. (2019). Comprehensive review on phytochemicals, pharmacological and clinical potentials of Gymnema sylvestre. Front Pharmacol, 10, 1223.
  54. Keskin M, Kaya G, Keskin Ş. (2021). Gundelia tournefortii L. (Kenger): determination of in vitro antidiabetic activities. Prog Nutr, 23(4), 1-7.
  55. King K, Lin NP, Cheng YH, Chen GH, Chein RJ. (2015). Isolation of positive modulator of glucagon-like peptide-1 signaling from Trigonella foenum-graecum (fenugreek) seed. J Biol Chem, 290, 26235-26248.
  56. Khound R, Shen J, Song Y, Santra D, Su Q. (2018). Phytoceuticals in fenugreek ameliorate VLDL overproduction and insulin resistance via the Insig signaling pathway. Mol Nutr Food Res, 62, 1700566.
  57. Komalasari T, Harimurti S. (2015). A review on the anti-diabetic activity of Andrographis paniculata (Burm. f.) Nees based in-vivo study. Int J Public Heal Sci, 4(4), 256–263.
  58. Konarska A, Domaciuk M. (2018). Differences in the fruit structure and the location and content of bioactive substances in Viburnum opulus and Viburnum lantana fruits. Protoplasma, 255, 25-41.
  59. Koupý D, Rudá-Kucerová J. (2015). Efficacy of phytotherapy in the treatment of type 2 diabetes mellitus. Interní Med Pro Praxi, 17, 240-242.
  60. Kumar S, Singh B, Bajpai V. (2021). Andrographis paniculata (Burm. f.) Nees: Traditional uses, phytochemistry, pharmacological properties and quality control/quality assurance. J Ethnopharmacol, 275, 114054.
  61. Kumar SR, Ashish J, Satish N. (2011). Momordica charantia Linn: A mini review. Int J Biomed Res, 11, 579-587.
  62. Kumar SN, Mani UV, Mani I. (2010). An open label study on the supplementation of Gymnema sylvestre in type 2 diabetics. J Diet Suppl, 7(3), 273-282.
  63. Kumar Shetty A, Suresh Kumar G, Veeraya Salimath P. (2005). Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats. Mol Nutr Food Res, 49, 791–796.
  64. Kutlu G, Erol KF. (2025). An in vitro assessment of the bioactive, cytotoxic, and antidiabetic potential of different parts of tumbleweed (Gundelia tournefortii L.). Gida, 50(1), 28-41.
  65. Leone A, Fico G, Bertoli S, Battezzati A. (2022). Editorial: Plant-based products, phytochemicals and glycemic control. Front Endocrinol (Lausanne), 13, 906690.
  66. Liu Z, Gong J, Huang W, Lu F, Dong H. (2021). The effect of Momordica charantia in the treatment of diabetes mellitus: A review. Evid Based Complement Alternat Med, 3796265.
  67. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. (2016). Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus – mechanisms, management, and clinical considerations. Circulation, 133(24), 2459-2502.
  68. Malekshahi H, Bahrami G, Miraghaee S, Ahmadi SA, Sajadimajd S et al. (2019). Momordica charantia reverses type II diabetes in rat. J Food Biochem, 43(11), e13021.
  69. Mishal A, Saravanan R, Atchitha SS, Santhiya K, Rithika M et al. (2020). Effect of Gymnema sylvestre leaf extract on streptozotocin induced diabetic rats. J Pharmacogn Phytochem, 9(4), 20-23.
  70. Mishra SK, Sangwan NS, Sangwan RS. (2007). Andrographis paniculata (Kalmegh): A review. Pharmacogn Rev, 1, 283-298.
  71. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TPA. (2007). Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr, 40(3), 163-173.
  72. Mokgalaboni K, Dlamini S, Phoswa WN, Modjadji P, Lebelo SL. (2023). The impact of Punica granatum Linn and its derivatives on oxidative stress, inflammation, and endothelial function in diabetes mellitus: evidence from preclinical and clinical studies. Antioxidants (Basel), 12(8), 1566.
  73. Naicker N, Nagiah S, Phulukdaree A, Chuturgoon A. (2016). Trigonella foenum-graecum seed extract, 4-hydroxyisoleucine, and metformin stimulate proximal insulin signaling and increase expression of glycogenic enzymes and GLUT2 in HepG2 cells. Metab Syndr Relat Disord, 14, 114-120.
  74. Nakatani N, Kayano S, Kikuzaki H, Sumino K, Katagiri K et al. (2000). Identification, quantitative determination, and antioxidative activities of chlorogenic acid isomers in prune (Prunus domestica L.). J Agric Food Chem, 48, 5512-5516.
  75. Nemzer BV, Kalita D, Yashin AY, Yashin YI. (2020). Bioactive compounds, antioxidant activities, and health beneficial effects of selected commercial berry fruits: a review. Antioxidants (Basel), 9(5), 468.
  76. Nugroho A, Andrie M, Warditiani NK, Siswanto E, Pramono S et al. (2012). Antidiabetic and antihyperlipidemic activities of Andrographis paniculata (Burm. f.) Nees and andrographolide in high fructose-fat fed rats. J Appl Pharm Sci, 2(11), 99-103.
  77. Nugroho AE, Kusumaramdani G, Widyaninggar A, Anggoro DP, Pramono S. (2014). Antidiabetic effect of combinations of n-hexane insoluble fraction of ethanolic extract of Andrographis paniculata with other traditional medicines. Int Food Res J, 21(2), 785–789.
  78. Oh YS, Jun HS. (2014). Role of bioactive food components in diabetes prevention: effects on beta-cell function and preservation. Nutr Metab Insights, 7, 51–59.
  79. Olvera-Sandoval C, Fabela-Illescas HE, Fernández-Martínez E, Ortiz-Rodríguez MA, Cariño-Cortés R et al. (2022). Potential mechanisms of the improvement of glucose homeostasis in type 2 diabetes by pomegranate juice. Antioxidants (Basel), 11(3), 553.
  80. Peková L, Žiarovská J, Fernández-Cusimamani E. (2023). Medicinal plants with antidiabetic activity used in the traditional medicine in Bolivia: A review. Bol Latinoam Caribe Plantas Med Aromat, 22(4), 442-456.
  81. Persaud SJ, Majed HA, Raman A, Jones PM. (1999). Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability. J Endocrinol, 163(2), 207–212.
  82. Potdar D, Hirwani RR, Dhulap S. (2012). Phytochemical and pharmacological applications of Berberis aristata. Fitoterapia, 83, 817-830.
  83. Rahman A, Shahwar D, Choudhary MI, Sener B, Toker G et al. (2000). Triterpenoid saponins from Bongardia chrysogonum. J Nat Prod, 63(2), 251-253.
  84. Raafat K, Samy W. (2014). Amelioration of diabetes and painful diabetic neuropathy by Punica granatum L. extract and its spray dried biopolymeric dispersions. Evid Based Complement Alternat Med, 180495.
  85. Razaq ZM, Dawood YA, Abdul-Jalil TZ, Al-Fadal S. (2025). Phytoscreening and isolation of some phenolic compounds from the Iraqi Gundelia tournefortii and detecting the antioxidant activity of its crude extract. J Med Plants By-prod, 14, 55-63.
  86. Saka WA, Oyekunle OS, Akhigbe TM, Oladipo OO, Ajayi MB et al. (2024). Andrographis paniculata improves glucose regulation by enhancing insulin sensitivity and upregulating GLUT4 expression in Wistar rats. Front Nutr, 11, 1416641.
  87. Shabil M, Bushi G, Bodige PK, Maradi PS, Patra BP et al. (2023). Effect of fenugreek on hyperglycemia: a systematic review and meta-analysis. Medicina (Kaunas), 59, 248.
  88. Singh S, Chaurasia PK, Bharati S. (2023). Hypoglycemic and hypocholesterolemic properties of fenugreek: a comprehensive assessment. Appl Food Res, 3, 100311.
  89. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K et al. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract, 183, 109119.
  90. Syamsul ES, Nugroho AE, Pramono S. (2011). Aktivitas antidiabetes kombinasi ekstrak terpurifikasi herba sambiloto (Andrographis paniculata (Burm. f.) Nees) dan metformin pada tikus DM tipe 2 resisten insulin. Majalah Obat Tradisional, 16(3), 124–131.
  91. Syvänne M, Taskinen MR. (1997). Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet, 350(Suppl 1), SI20-SI23.
  92. Tabeshpour J, Imenshahidi M, Hosseinzadeh H. (2017). A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome. Iran J Basic Med Sci, 20(5), 557-568.
  93. Tahmasebi L, Zakerkish M, Golfakhrabadi F, Namjoyan F. (2019). Randomised clinical trial of Berberis vulgaris root extract on glycemic and lipid parameters in type 2 diabetes mellitus patients. Eur J Integr Med, 32, 100998.
  94. Tang D, Liu L, Ajiakber D, Ye J, Xu J et al. (2018). Anti-diabetic effect of Punica granatum flower polyphenols extract in type 2 diabetic rats: activation of Akt/GSK-3β and inhibition of IRE1α-XBP1 pathways. Front Endocrinol (Lausanne), 9, 586.
  95. Taskiran A, Kasikçi ES, Sahin KF, Çevreli B et al. (2020). Effects of highbush cranberry (Viburnum opulus) on hyperglycemia and oxidative damage in the kidney of streptozotocin-induced diabetic rats. J Neurobehav Sci, 7(2), 61-65.
  96. Tran N, Pham B, Le L. (2020). Bioactive compounds in anti-diabetic plants: From herbal medicine to modern drug discovery. Biology (Basel), 9(9), 252.
  97. Uebanso T, Arai H, Taketani Y, Fukaya M, Yamamoto H et al. (2007). Extracts of Momordica charantia suppress postprandial hyperglycemia in rats. J Nutr Sci Vitaminol (Tokyo), 53, 482–488.
  98. World Health Organization (2020). WHO report reveals diabetes among the top 10 causes of death and disability worldwide. WHO. Erişim adresi: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
  99. World Health Organization (2024). Diabetes. WHO. Erişim adresi: https://www.who.int/news-room/fact-sheets/detail/diabetes.
  100. Xie W, Su F, Wang G, Peng Z, Xu Y et al. (2022). Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Front Pharmacol, 13, 1015045.
  101. Xue W, Lei J, Li X, Zhang R. (2011). Trigonella foenum-graecum seed extract protects kidney function and morphology in diabetic rats via its antioxidant activity. Nutr Res, 31, 555-562.
  102. Vignozzi L, Morelli A, Coronabastianelli A, Serni S, Gacci M et al. (2012). Testosterone protects the lower urinary tract from metabolic syndrome-induced alterations. Horm Mol Biol Clin Investig, 11(2), 353–361.
  103. Yadav UC, Baquer NZ. (2014). Pharmacological effects of Trigonella foenum-graecum L. in health and disease. Pharm Biol, 52(2), 243-254.
  104. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW et al. (2012). Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35, 556–564.
  105. Yıldız R, Ekici H. (2019). Gilaburu (Viburnum opulus L.)’nun farmakolojik açıdan değerlendirilmesi. Vet Farmakol Toksikol Derneği Bülteni, 10, 16-23.
  106. Yibchok-anun S, Jittaprasatsin W, Somtir D, Bunlunara W, Adisakwattana S. (2009). Insulin secreting and α-glucosidase inhibitory activity of Coscinium fenestratum and postprandial hyperglycemia in normal and diabetic rats. J Med Plants Res, 3(9), 646-651.
  107. Yoshikawa M, Murakami T, Komatsu H, Murakami N, Yamahara J et al. (1997). Medicinal foodstuffs: IV. Fenugreek seeds (1): structures of trigoneosides Ia, Ib, IIb, IIIa and IIIb, new furostanol saponins from the seeds of Indian Trigonella foenum-graecum L. Chem Pharm Bull, 45, 81-87.
  108. Yürüker A. (1993). Viburnum orientale Pallas üzerinde fitokimyasal çalışmalar. Doktora tezi, Hacettepe Üniversitesi Sağlık Bilimleri Enstitüsü, Ankara.
  109. Zakłos-Szyda M, Kowalska-Baron A, Pietrzyk N, Drzazga A, Podsędek A. (2020). Evaluation of Viburnum opulus L. fruit phenolics cytoprotective potential on insulinoma MIN6 cells relevant for diabetes mellitus and obesity. Antioxidants (Basel), 9(5), 433.
  110. Zarifikhosroshahi M. (2015). Gilaburu (Viburnum opulus L.) meyvelerinde biyoaktif, biyokimyasal ve besin element içeriklerinin belirlenmesi. Yüksek lisans tezi, Çukurova Üniversitesi Fen Bilimleri Enstitüsü.